Molecular Determinants of Ethionamide Resistance in Clinical Isolates of Mycobacterium tuberculosis

Background: Ethionamide and prothionamide are now included in group C of the WHO recommended drugs for the treatment of tuberculosis resistant to rifampicin and multidrug-resistant tuberculosis. The clinical relevance of ethionamide and prothionamide has increased with the wide spread of resistant t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ushtanit, Anastasia, Kulagina, Elena, Mikhailova, Yulia, Makarova, Marina, Safonova, Svetlana, Zimenkov, Danila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868424/
https://www.ncbi.nlm.nih.gov/pubmed/35203736
http://dx.doi.org/10.3390/antibiotics11020133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868424/
https://www.ncbi.nlm.nih.gov/pubmed/35203736
http://dx.doi.org/10.3390/antibiotics11020133

Ejemplares similares